Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Mitessh Thakkar of mitesshthakkar.com suggests selling Ambuja Cements and HCC.
What a dream run it has been for the Indian equity market in 2017 - and who would have thought. If we rewind back and talk about all the gloom and doom that were surrounding us back in December of 2016; demonetisation and impending huge indirect tax reform. Well, the Indian market has come a long way and come on top. In this CNBC-TV18 special show '18 for 18', SP Tulsian of sptulsian.com gave top stock ideas for 2018.
What a dream run it has been for the Indian equity market in 2017 - and who would have thought. If we rewind back and talk about all the gloom and doom that were surrounding us back in December of 2016; demonetisation and impending huge indirect tax reform. Well, the Indian market has come a long way and come on top.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on the market and specific stocks and sectors.
Market expert SP Tulsian of SPTulsian.com told CNBC-TV18 that he is positive on Maruti Suzuki and from a valuation perspective it becomes a very good buy at sub-Rs 5,000 levels. He expects the carmaker‘s sales to be not as impressive as November‘s.
SP Tulsian bets on Maruti, says if the stock price falls to around Rs 5,000 then it is a buy and if it comes to a level of about Rs 5,300 then there is no harm in booking profits.
In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shared his outlook on pharmaceutical and real estate sectors. He also discussed his take on Reliance Capital's sale of radio and TV businesses to Zee Entertainment and what it means for these stocks.
SP Tulsian of sptulsian.com sees good growth potential in Cineline India with target price of Rs 100 by next Diwali.
Only 8-10 movies of the 150-160 are raking the moolah at the box office, says SP Tulsian of sptulsian.com.
In an interview to CNBC-TV18, SP Tulsian shares his views on metal stocks and Quess Corp's stellar IPO listing.
SP Tulsian, sptulsian.com in an interview to CNBC-TV18 while sharing his views why 8K Miles does not warrant a buy at current levels and why he is bullish on the pharma space.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the public sector undertaking (PSU) banking space.
SP Tulsian of sptulsian.com is of the veiw that Cineline India may become a five bagger or ten bagger in next two to three years.